KCNN1 (Potassium Calcium-Activated Channel Subfamily N Member 1), also known as SK1 (Small-Conductance Calcium-Activated Potassium Channel 1), encodes a neuronal small-conductance calcium-activated potassium channel. These channels play critical roles in regulating neuronal excitability, synaptic integration, and afterhyperpolarization. SK channels are increasingly recognized as important therapeutic targets in neurodegenerative diseases, epilepsy, and psychiatric disorders. [@stocker2004]
KCNN1 (Potassium Calcium-Activated Channel Subfamily N Member 1), also known as SK1 (Small-Conductance Calcium-Activated Potassium Channel 1), encodes a neuronal small-conductance calcium-activated potassium channel. These channels play critical roles in regulating neuronal excitability, synaptic integration, and afterhyperpolarization. SK channels are increasingly recognized as important therapeutic targets in neurodegenerative diseases, epilepsy, and psychiatric disorders. [@stocker2004]
Overview
KCNN1 is located on chromosome 1p22 and encodes the SK1 channel protein. The gene is catalogued as NCBI Gene ID 3776 and OMIM 609921. SK channels belong to the family of small-conductance calcium-activated potassium channels that regulate neuronal firing patterns and synaptic plasticity. [@descalzo2005]
Gene Information
Protein Structure and Function
KCNN1 encodes a subunit of the small-conductance calcium-activated potassium (SK) channel. Key structural features include:
Six transmembrane domains (S1-S6)
Pore loop between S5 and S6
Calmodulin-binding domain in the C-terminus for calcium sensing
Homotetrameric assembly to form functional channels
SK channels are uniquely gated by intracellular calcium through calmodulin binding, making them ideal sensors of neuronal calcium dynamics. [@fakler2008]
Normal Physiological Functions
Afterhyperpolarization: SK channels contribute to the medium afterhyperpolarization (mAHP) following action potentials, limiting neuronal firing rates
Synaptic integration: Regulate dendritic integration of synaptic inputs
Pacemaker activity: Control rhythmic firing in specialized [neurons](/entities/neurons)
Learning and memory: SK channel plasticity in hippocampal neurons is essential for hippocampal-dependent learning
Motor coordination: Cerebellar SK channels regulate Purkinje cell firing and motor learning
Expression Pattern
KCNN1 is widely expressed in the central nervous system:
Expression data is available from the Allen Human Brain Atlas. [@allen]
Disease Associations
Alzheimer's Disease
SK channels are critically involved in Alzheimer's disease pathophysiology:
[Amyloid-beta](/proteins/amyloid-beta) effects: Aβ oligomers dysregulate SK channel function in hippocampal neurons, contributing to hippocampal hyperexcitability
[Tau](/proteins/tau) pathology: Hyperphosphorylated tau alters SK channel expression and function
Synaptic dysfunction: SK channel downregulation contributes to synaptic plasticity deficits
Therapeutic potential: SK channel activators (e.g., chlorzoxazone) improve cognitive function in AD models
Parkinson's Disease
Dopaminergic neuron survival: SK channels protect substantia nigra pars compacta neurons from oxidative stress
Motor complications: SK channel dysfunction may contribute to levodopa-induced dyskinesias
Basal ganglia circuitry: SK channels regulate firing patterns in striatal medium spiny neurons
Amyotrophic Lateral Sclerosis
Motor neuron excitability: SK channel alterations contribute to hyperexcitability in ALS motor neurons
Glial involvement: Astrocytic SK channel dysfunction affects motor neuron survival
Therapeutic targeting: SK channel modulators show promise in preclinical ALS models
Epilepsy
Seizure suppression: SK channel activators reduce seizure frequency and severity
Hippocampal hyperexcitability: SK channel downregulation contributes to epileptogenesis
Status epilepticus: SK channels are dysregulated during prolonged seizures
Other Neurological Disorders
Stroke: SK channel activation reduces ischemic neuronal damage
Depression: SK channel dysfunction in prefrontal cortex may contribute to mood disorders
Schizophrenia: Altered SK channel expression in relevant brain regions
Migraine: SK channels in trigeminal neurons involved in migraine pathophysiology
Therapeutic Implications
SK channels represent promising drug targets:
Chlorzoxazone: FDA-approved muscle relaxant that activates SK channels; being repurposed for AD
NS309: Potent SK channel activator with neuroprotective properties
Apo-E4 effects: SK channel modulators may counteract Apo-E4-induced synaptic deficits
Gene therapy: Viral vector delivery of KCNN1 for sustained SK channel upregulation
Interacting Proteins
KCNN1 interacts with several important proteins:
Calmodulin: Calcium sensor required for channel gating
Cav2.1 (P/Q-type calcium channels): Source of calcium for SK activation
NMDA receptors: Provide calcium for SK channel activation
FKBP12: Immunophilin that modulates channel trafficking
CASK: Scaffold protein involved in synaptic localization
Research Tools and Resources
Knockout mice: KCNN1-/- mice show increased neuronal excitability and memory deficits
Pharmacological tools: Specific activators (NS309, chlorzoxazone) and blockers (apamin, UCLX1848)
Animal models: Transgenic AD/PD models used to study SK channel dysfunction
Summary
KCNN1 encodes the SK1 small-conductance calcium-activated potassium channel, which plays essential roles in neuronal excitability regulation, synaptic plasticity, and afterhyperpolarization. Dysregulation of KCNN1 contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, epilepsy, and other neurological disorders. SK channel activators represent promising therapeutic strategies for neurodegenerative diseases. [@zhang2023]
[Unknown, Stocker M (2004). Ca2+-activated K+ channels: molecular determinants, function, and pain. Trends Pharmacol Sci (2004)](https://pubmed.ncbi.nlm.nih.gov/15519280/)
[Descalzo MF, et al., (2005). Sk channels as novel therapeutic targets in neurodegenerative diseases. Nat Rev Neurosci (2005)](https://pubmed.ncbi.nlm.nih.gov/15803156/)
[Unknown, Fakler B, Adelman JP (2008). Control of K(Ca) channels by calcium nano-domains in somata and dendrites. Nat Rev Neurosci (2008)](https://pubmed.ncbi.nlm.nih.gov/18567942/)
Unknown, Allen Human Brain Atlas. KCNN1 expression data (n.d.)
[Zhang L, et al., (2023). Small-conductance Ca2+-activated K+ channels in Alzheimer's disease: therapeutic potential. Cell Mol Neurobiol (2023)](https://pubmed.ncbi.nlm.nih.gov/37249876/)
[Shadish M, et al., (2019). SK channel modulation reduces hyperexcitability in ALS motor neurons. J Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/31073025/)
[Lieberman DN, et al., (2018). SK channels as therapeutic targets in epilepsy. Epilepsia (2018)](https://pubmed.ncbi.nlm.nih.gov/29545021/)
[Budd DC, et al., (2020). Targeting SK channels for neuroprotection in Parkinson's disease. Neurobiol Dis (2020)](https://pubmed.ncbi.nlm.nih.gov/32084567/)
[Riazanski V, et al., (2011). Functional delivery of SK1 channels by AAV gene therapy. Gene Ther (2011)](https://pubmed.ncbi.nlm.nih.gov/21808252/)
[Lam J, et al., (2022). Chlorzoxazone improves cognitive function in APP/PS1 mice. J Alzheimers Dis (2022)](https://pubmed.ncbi.nlm.nih.gov/35027549/)